Stillwater Capital Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$40.7M Sell
33,909
-142
-0.4% -$145K 4.15% 8
2026
Q1
$31.3M Sell
34,051
-315
-0.9% -$319K 3.57% 9
2025
Q4
$36.9M Buy
34,366
+95
+0.3% +$90.8K 3.97% 7
2025
Q3
$26.1M Buy
34,271
+33,040
+2,684% +$24.6M 2.94% 10
2025
Q2
$960K Sell
1,231
-70
-5% -$54.4K 0.12% 48
2025
Q1
$1.07M Buy
1,301
+207
+19% +$172K 0.15% 48
2024
Q4
$845K Hold
1,094
0.1% 53
2024
Q3
$969K Buy
+1,094
New +$984K 0.13% 51
2024
Q2
Sell
-1,104
Closed -$859K 60
2024
Q1
$859K Hold
1,104
0.13% 52
2023
Q4
$643K Hold
1,104
0.1% 56
2023
Q3
$593K Buy
1,104
+10
+0.9% +$5.15K 0.11% 57
2023
Q2
$513K Hold
1,094
0.09% 59
2023
Q1
$376K Hold
1,094
0.07% 59
2022
Q4
$400K Hold
1,094
0.08% 57
2022
Q3
$354K Sell
1,094
-167
-13% -$52.9K 0.08% 58
2022
Q2
$409K Buy
1,261
+469
+59% +$141K 0.08% 63
2022
Q1
$227K Hold
792
0.04% 71
2021
Q4
$219K Buy
+792
New +$201K 0.03% 71

Other funds holding LLY

Stillwater Capital Advisors's LLY Position: Q2 2026 in Review

Stillwater Capital Advisors reduced its Eli Lilly (LLY) stake by 0.42% in Q2 2026, selling an estimated $145K and leaving 33,909 shares worth $40.7M. The position accounts for 4.15% of the portfolio, ranked #8.

Stillwater Capital Advisors first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. 4,635 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Stillwater Capital Advisors held 33,909 shares of Eli Lilly worth $40.7M as of Q2 2026.
  • Stillwater Capital Advisors sold 142 Eli Lilly shares in Q2 2026, an estimated $145K.
  • Eli Lilly made up 4.15% of Stillwater Capital Advisors's portfolio in Q2 2026, its #8 holding.
  • Stillwater Capital Advisors first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
  • 4,635 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Stillwater Capital Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.